PTCT · PTC Therapeutics Inc
United States · RS rating 63 · As of 2026-11-03
| Price | 68.12 USD |
|---|---|
| 1-day change | +11.9% |
| RS rating (overall / 1M / 3M / 12M) | 63 / 76 / 63 / 50 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 32 / 22 / 22 |
| Industry group (rank) | Medical-Biomed/Biotech (154) |
| EPS growth Q/Q | -935.0% |
| Sales growth Q/Q | -22.0% |
| Distance from 52-week high | +23.9% |
| Market cap (USD) | $5.7B |